These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27836713)

  • 1. Early enteric neuron dysfunction in mouse and human Huntington disease.
    Sciacca S; Favellato M; Madonna M; Metro D; Marano M; Squitieri F
    Parkinsonism Relat Disord; 2017 Jan; 34():73-74. PubMed ID: 27836713
    [No Abstract]   [Full Text] [Related]  

  • 2. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
    Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
    Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
    J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huntington modeling improves with age.
    Mattis VB; Svendsen CN
    Nat Neurosci; 2018 Mar; 21(3):301-303. PubMed ID: 29476127
    [No Abstract]   [Full Text] [Related]  

  • 5. p35 hemizygosity activates Akt but does not improve motor function in the YAC128 mouse model of Huntington's disease.
    Park KHJ; Franciosi S; Parrant K; Lu G; Leavitt BR
    Neuroscience; 2017 Jun; 352():79-87. PubMed ID: 28391013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice.
    Polyzos AA; Lee DY; Datta R; Hauser M; Budworth H; Holt A; Mihalik S; Goldschmidt P; Frankel K; Trego K; Bennett MJ; Vockley J; Xu K; Gratton E; McMurray CT
    Cell Metab; 2019 Jun; 29(6):1258-1273.e11. PubMed ID: 30930170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
    Sebastianutto I; Cenci MA; Fieblinger T
    Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease.
    Shekhar S; Vatsa N; Kumar V; Singh BK; Jamal I; Sharma A; Jana NR
    Hum Mol Genet; 2017 Jan; 26(2):420-429. PubMed ID: 28007908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease.
    Sutton LM; Sanders SS; Butland SL; Singaraja RR; Franciosi S; Southwell AL; Doty CN; Schmidt ME; Mui KK; Kovalik V; Young FB; Zhang W; Hayden MR
    Hum Mol Genet; 2013 Feb; 22(3):452-65. PubMed ID: 23077216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel humanized mouse model of Huntington disease for preclinical development of therapeutics targeting mutant huntingtin alleles.
    Southwell AL; Skotte NH; Villanueva EB; Østergaard ME; Gu X; Kordasiewicz HB; Kay C; Cheung D; Xie Y; Waltl S; Dal Cengio L; Findlay-Black H; Doty CN; Petoukhov E; Iworima D; Slama R; Ooi J; Pouladi MA; Yang XW; Swayze EE; Seth PP; Hayden MR
    Hum Mol Genet; 2017 Mar; 26(6):1115-1132. PubMed ID: 28104789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
    García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
    J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing mutant huntingtin proteolysis and intermittent fasting promote autophagy in models of Huntington disease.
    Ehrnhoefer DE; Martin DDO; Schmidt ME; Qiu X; Ladha S; Caron NS; Skotte NH; Nguyen YTN; Vaid K; Southwell AL; Engemann S; Franciosi S; Hayden MR
    Acta Neuropathol Commun; 2018 Mar; 6(1):16. PubMed ID: 29510748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR
    BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
    Pouladi MA; Stanek LM; Xie Y; Franciosi S; Southwell AL; Deng Y; Butland S; Zhang W; Cheng SH; Shihabuddin LS; Hayden MR
    Hum Mol Genet; 2012 May; 21(10):2219-32. PubMed ID: 22328089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.
    Slow EJ; Graham RK; Osmand AP; Devon RS; Lu G; Deng Y; Pearson J; Vaid K; Bissada N; Wetzel R; Leavitt BR; Hayden MR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11402-7. PubMed ID: 16076956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative disease: neuron protection agency.
    Orr HT
    Nature; 2004 Oct; 431(7010):747-8. PubMed ID: 15483586
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease.
    Batcha AH; Greferath U; Jobling AI; Vessey KA; Ward MM; Nithianantharajah J; Hannan AJ; Kalloniatis M; Fletcher EL
    Neurobiol Dis; 2012 Mar; 45(3):887-96. PubMed ID: 22198376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.